» Articles » PMID: 28208170

Optical Coherence Tomographic Angiography in Type 2 Diabetes and Diabetic Retinopathy

Overview
Journal JAMA Ophthalmol
Specialty Ophthalmology
Date 2017 Feb 17
PMID 28208170
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: Optical coherence tomographic angiography (OCT-A) is able to visualize retinal microvasculature without the need for injection of fluorescein contrast dye. Nevertheless, it is only able to capture a limited view of macula and does not show leakage.

Objectives: To evaluate the retinal microvasculature using OCT-A in patients with type 2 diabetes as well as the association of OCT-A characteristics with diabetic retinopathy (DR) and systemic risk factors.

Design, Setting, And Participants: A prospective, observational study was conducted from January 1 to June 30, 2016, at medical retina clinics at the Singapore National Eye Center among 50 patients with type 2 diabetes with and without DR (n = 100 eyes). We examined the retinal microvasculature with swept-source OCT-A and a semiautomated software to measure the capillary density index (CDI) and fractal dimension (FD) at the superficial vascular plexus (SVP) and deep retinal vascular plexus (DVP). We collected data on histories of patients' glycated hemoglobin A1c, hypertension, hyperlipidemia, smoking, and renal impairment.

Main Outcomes And Measures: The CDI and FD at the SVP and DVP for each severity level of DR and the association of systemic risk factors vs the CDI and FD.

Results: The mean (SD) glycated hemoglobin A1c of the 50 patients (26 men and 24 women; 35 Chinese; mean [SD] age, 59.5 [8.9] years) was 7.9% (1.7%). The mean (SD) CDI at the SVP decreased from 0.358 (0.017) in patients with no DR to 0.338 (0.012) in patients with proliferative DR (P < .001) and at the DVP decreased in patients with no DR from 0.361 (0.019) to 0.345 (0.020) in patients with proliferative DR (P = .04). The mean (SD) FD at the SVP increased from 1.53 (0.05) in patients with no DR to 1.60 (0.05) in patients with proliferative DR (P < .01) and at the DVP increased from 1.55 (0.06) in patients with no DR to 1.61 (0.05) in patients with proliferative DR (P = .02). For systemic risk factors, hyperlipidemia (odds ratio [OR], 9.82; 95% CI, 6.92-11.23; P < .001), smoking (OR, 10.90; 95% CI, 8.23-12.34; P < .001), and renal impairment (OR, 3.72; 95% CI, 1.80-4.81; P = .05) were associated with reduced CDI, while increased glycated hemoglobin A1c (≥8%) (OR, 8.77; 95% CI, 5.23-10.81; P < .01) and renal impairment (OR, 10.30; 95% CI, 8.21-11.91; P < .001) were associated with increased FD.

Conclusions And Relevance: Optical coherence tomographic angiography is a novel imaging modality to quantify the retinal capillary microvasculature in patients with diabetes. It can be potentially used in interventional trials to study the effect of systemic risk factors on the microvasculature that was previously not accessible in a noninvasive manner. The relevance of these findings relative to visual acuity, however, remains largely unknown at this time.

Citing Articles

Reduced retinal microvascular density in women with coronary microvascular dysfunction: A pilot study.

Shiromani S, AlBadri A, Lindeke-Myers A, Schwartz A, Vatsa N, Dave E Am Heart J Plus. 2025; 51:100502.

PMID: 39995513 PMC: 11847120. DOI: 10.1016/j.ahjo.2025.100502.


Retinal and Choroidal Vascularization Parameters in Patients with Type 2 Diabetes Without Diabetic Retinopathy.

Malyszczak A, Przezdziecka-Dolyk J, Szydelko-Pasko U, Misiuk-Hojlo M Clin Ophthalmol. 2024; 18:3019-3029.

PMID: 39473830 PMC: 11520712. DOI: 10.2147/OPTH.S480207.


Blue Wavelength of Scanning Laser Ophthalmoscope Potentially Detects Arteriosclerotic Lesions in Diabetic Retinopathy.

Horie S, Suzuki Y, Yoshida T, Ohno-Matsui K Diagnostics (Basel). 2024; 14(13).

PMID: 39001301 PMC: 11241710. DOI: 10.3390/diagnostics14131411.


The Role of Widefield Optical Coherence Tomography Angiography in Assessing the Severity of Diabetic Retinopathy.

Parameswarappa D, Langstang A, Kavya S, Mohamed A, Stewart M, Rani P Ophthalmol Ther. 2024; 13(9):2369-2380.

PMID: 38995480 PMC: 11341797. DOI: 10.1007/s40123-024-00995-y.


Imaging Modalities for Assessing the Vascular Component of Diabetic Retinal Disease: Review and Consensus for an Updated Staging System.

Tan T, Jampol L, Ferris F, Tadayoni R, Sadda S, Chong V Ophthalmol Sci. 2024; 4(3):100449.

PMID: 38313399 PMC: 10837643. DOI: 10.1016/j.xops.2023.100449.